{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T05:19:06Z","timestamp":1722835146821},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2014,11,19]],"date-time":"2014-11-19T00:00:00Z","timestamp":1416355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s12026-014-8599-8","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T16:34:16Z","timestamp":1416587656000},"page":"330-338","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21low B cells"],"prefix":"10.1007","volume":"60","author":[{"given":"Milica","family":"Mitrevski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Marrapodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Camponeschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Lazzeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Todi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Quinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Fiorilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"Visentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,19]]},"reference":[{"key":"8599_CR1","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","volume":"367","author":"E Gelfand","year":"2012","unstructured":"Gelfand E. Intravenous immune globulin in autoimmune and inflammatory diseases. N Engl J Med. 2012;367:2015\u201325.","journal-title":"N Engl J Med"},{"key":"8599_CR2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2010.10.030","volume":"127","author":"M Ballow","year":"2011","unstructured":"Ballow M. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol. 2011;127:315\u201323.","journal-title":"J Allergy Clin Immunol"},{"key":"8599_CR3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","volume":"13","author":"I Schwab","year":"2013","unstructured":"Schwab I, Nimmerjahn F. Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol. 2013;13:176\u201389.","journal-title":"Nat Rev Immunol"},{"key":"8599_CR4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","volume":"313","author":"Y Kaneko","year":"2006","unstructured":"Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006;313:670\u20133.","journal-title":"Science"},{"key":"8599_CR5","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1182\/blood-2009-12-261461","volume":"116","author":"JF Seit\u00e9","year":"2010","unstructured":"Seit\u00e9 JF, Cornec D, Renaudineau Y, Youinou P, Mageed RA, Hillion S. IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes. Blood. 2010;116:1698\u2013704.","journal-title":"Blood"},{"key":"8599_CR6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood-2002-05-1447","volume":"101","author":"J Bayry","year":"2003","unstructured":"Bayry J, Lacroix-Desmazes S, Carbonneil C, Misra N, Donkova V, Pashov A, et al. Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood. 2003;101:758\u201365.","journal-title":"Blood"},{"key":"8599_CR7","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1182\/blood-2013-04-499442","volume":"121","author":"D Paquin-Proulx","year":"2013","unstructured":"Paquin-Proulx D, Santos BA, Carvalho KI, Toledo-Barros M, Oliveira AK, Kokron CM, et al. Dysregulated CD1 profile in myeloid dendritic cells in CVID is normalized by IVIg treatment. Blood. 2013;121:4963\u20134.","journal-title":"Blood"},{"key":"8599_CR8","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.4049\/jimmunol.179.8.5571","volume":"179","author":"A Kessel","year":"2007","unstructured":"Kessel A, Ammuri H, Peri R, Pavlotzky ER, Blank M, Shoenfeld Y, et al. Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function. J Immunol. 2007;179:5571\u20135.","journal-title":"J Immunol"},{"key":"8599_CR9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1182\/blood-2007-03-079947","volume":"111","author":"A Ephrem","year":"2008","unstructured":"Ephrem A, Chamat S, Miquel C, Fisson S, Mouthon L, Caligiuri G, et al. Expansion of CD4+ CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood. 2008;111:715\u201322.","journal-title":"Blood"},{"key":"8599_CR10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.autrev.2012.08.017","volume":"12","author":"LP Cousens","year":"2013","unstructured":"Cousens LP, Tassone R, Mazer BD, Ramachandiran V, Scott DW, De Groot AS. Tregitope update: mechanism of action parallels IVIg. Autoimmun Rev. 2013;12:436\u201343.","journal-title":"Autoimmun Rev"},{"key":"8599_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10875-007-9082-2","volume":"27","author":"L Pottier Le","year":"2007","unstructured":"Le Pottier L, Bendaoud B, Dueymes M, Daridon C, Youinou P, Shoenfeld Y, et al. BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer. J Clin Immunol. 2007;27:257\u201365.","journal-title":"J Clin Immunol"},{"key":"8599_CR12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1196\/annals.1423.044","volume":"1110","author":"L Pottier Le","year":"2007","unstructured":"Le Pottier L, Sapir T, Bendaoud B, Youinou P, Shoenfeld Y, Pers JO. Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL. Ann NY Acad Sci. 2007;1110:426\u201332.","journal-title":"Ann NY Acad Sci"},{"key":"8599_CR13","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1073\/pnas.0807319106","volume":"106","author":"B Tackenberg","year":"2009","unstructured":"Tackenberg B, Jelcic I, Baerenwaldt A, Oertel WH, Sommer N, Nimmerjahn F, et al. Impaired inhibitory Fc\u03b3 receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy. Proc Natl Acad Sci USA. 2009;106:4788\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8599_CR14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/icb.2009.36","volume":"87","author":"KA Nikolova","year":"2009","unstructured":"Nikolova KA, Tchorbanov AI, Djoumerska-Alexieva IK, Nikolova M, Vassilev TL. Intravenous immunoglobulin up-regulates the expression of the inhibitory Fc\u03b3IIB receptor on B cells. Immunol Cell Biol. 2009;87:529\u201333.","journal-title":"Immunol Cell Biol"},{"key":"8599_CR15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ni1440","volume":"8","author":"Z Xiang","year":"2007","unstructured":"Xiang Z, Cutler AJ, Brownlie RJ, Fairfax K, Lawlor KE, Severinson E, et al. FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol. 2007;8:419\u201329.","journal-title":"Nat Immunol"},{"key":"8599_CR16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaci.2013.08.042","volume":"133","author":"JF S\u00e9it\u00e9","year":"2014","unstructured":"S\u00e9it\u00e9 JF, Goutsmedt C, Youinou P, Pers JO, Hillion S. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells. J Allergy Clin Immunol. 2014;133:181\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"8599_CR17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nri2133","volume":"7","author":"JC Cambier","year":"2007","unstructured":"Cambier JC, Gauld SB, Merrell KT, Vilen BJ. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol. 2007;7:633\u201343.","journal-title":"Nat Rev Immunol"},{"key":"8599_CR18","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1073\/pnas.0901984106","volume":"106","author":"M Rakhmanov","year":"2009","unstructured":"Rakhmanov M, Keller B, Gutenberger S, Foerster C, Hoenig M, Driessen G, et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci USA. 2009;106:13451\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8599_CR19","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","volume":"115","author":"I Isnardi","year":"2010","unstructured":"Isnardi I, Ng YS, Menard L, Meyers G, Saadoun D, Srdanovic I, et al. Complement receptor 2\/CD21\u2212 human naive B cells contain mostly autoreactive unresponsive clones. Blood. 2010;115:5026\u201336.","journal-title":"Blood"},{"key":"8599_CR20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/eji.201040862","volume":"41","author":"M Visentini","year":"2011","unstructured":"Visentini M, Cagliuso M, Conti V, Carbonari M, Mancaniello D, Cibati M, et al. Telomere-dependent replicative senescence of B and T cells from patients with type 1a common variable immunodeficiency. Eur J Immunol. 2011;41:854\u201362.","journal-title":"Eur J Immunol"},{"key":"8599_CR21","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.20072683","volume":"205","author":"S Moir","year":"2008","unstructured":"Moir S, Ho J, Malaspina A, Wang W, Di Poto AC, O\u2019Shea MA, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med. 2008;205:1797\u2013805.","journal-title":"J Exp Med"},{"key":"8599_CR22","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/eji.201142313","volume":"42","author":"M Visentini","year":"2012","unstructured":"Visentini M, Cagliuso M, Conti V, Carbonari M, Cibati M, Siciliano G, et al. Clonal B cells of HCV-associated mixed cryoglobulinemia patients contain exhausted marginal zone-like and CD21 low cells overexpressing Stra13. Eur J Immunol. 2012;42:1468\u201376.","journal-title":"Eur J Immunol"},{"key":"8599_CR23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.autrev.2012.08.016","volume":"12","author":"M Visentini","year":"2013","unstructured":"Visentini M, Conti V, Cristofoletti C, Lazzeri C, Marrapodi R, Russo G, et al. Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity. Autoimmun Rev. 2013;12:430\u20135.","journal-title":"Autoimmun Rev"},{"key":"8599_CR24","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2009.10.013","volume":"124","author":"LD Notarangelo","year":"2009","unstructured":"Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, et al. International union of immunological societies expert committee on primary immunodeficiencies. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009;124:1161\u201378.","journal-title":"J Allergy Clin Immunol"},{"key":"8599_CR25","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","volume":"99","author":"K Warnatz","year":"2002","unstructured":"Warnatz K, Denz A, Dr\u00e4ger R, Braun M, Groth C, Wolff-Vorbeck G, et al. Severe deficiency of switched memory B cells (CD27(+)IgM(\u2212)IgD(\u2212)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002;99:1544\u201351.","journal-title":"Blood"},{"key":"8599_CR26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1084\/jem.20050879","volume":"202","author":"GR Ehrhardt","year":"2005","unstructured":"Ehrhardt GR, Hsu JT, Gartland L, Leu CM, Zhang S, Davis RS, et al. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med. 2005;202:783\u201391.","journal-title":"J Exp Med"},{"key":"8599_CR27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clim.2011.01.002","volume":"139","author":"M Siedlar","year":"2011","unstructured":"Siedlar M, Strach M, Bukowska-Strakova K, Lenart M, Szaflarska A, W\u0119glarczyk K, et al. Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+ CD16++ monocytes in common variable immunodeficiency (CVID) patients. Clin Immunol. 2011;139:122\u201332.","journal-title":"Clin Immunol"},{"key":"8599_CR28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clim.2012.07.008","volume":"145","author":"AS Tjon","year":"2012","unstructured":"Tjon AS, Metselaar HJ, te Boekhorst PA, van Hagen PM, Kwekkeboom J. High-dose intravenous immunoglobulin does not reduce the numbers of circulating CD14(+)CD16(++) monocytes in patients with inflammatory disorders. Clin Immunol. 2012;145:11\u20132.","journal-title":"Clin Immunol"},{"key":"8599_CR29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"C Wehr","year":"2008","unstructured":"Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111:77\u201385.","journal-title":"Blood"},{"key":"8599_CR30","doi-asserted-by":"crossref","first-page":"75199","DOI":"10.1371\/journal.pone.0075199","volume":"8","author":"D Paquin-Proulx","year":"2013","unstructured":"Paquin-Proulx D, Santos BA, Carvalho KI, Toledo-Barros M, Barreto de Oliveira AK, Kokron CM, et al. IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID. PLoS ONE. 2013;8:75199.","journal-title":"PLoS ONE"},{"key":"8599_CR31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1034\/j.1600-6143.2003.00011.x","volume":"3","author":"M Toyoda","year":"2003","unstructured":"Toyoda M, Pao A, Petrosian A, Jordan SC. Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells. Am J Transplant. 2003;3:156\u201366.","journal-title":"Am J Transplant"},{"key":"8599_CR32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.clim.2010.01.001","volume":"135","author":"D Paquin Proulx","year":"2010","unstructured":"Paquin Proulx D, Aubin E, Lemieux R, Bazin R. Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg). Clin Immunol. 2010;135:422\u20139.","journal-title":"Clin Immunol"},{"key":"8599_CR33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0091-6749(98)70130-7","volume":"102","author":"K Sigman","year":"1998","unstructured":"Sigman K, Ghibu F, Sommerville W, Toledano B, Bastein Y, Cameron L, et al. Intravenous immunoglobulin inhibits IgE production in human B lymphocytes. J Allergy Clin Immunol. 1998;102:421\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"8599_CR34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1067\/mai.2001.116291","volume":"108","author":"Q Zhuang","year":"2001","unstructured":"Zhuang Q, Mazer B. Inhibition of IgE production in vitro by intact and fragmented intravenous immunoglobulin. J Allergy Clin Immunol. 2001;108:229\u201334.","journal-title":"J Allergy Clin Immunol"},{"key":"8599_CR35","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2002-06-1684","volume":"101","author":"M Grandmont de","year":"2003","unstructured":"de Grandmont M, Racine C, Roy A, Lemieux R, Neron S. Intravenous immuno-globulins induce the in vitro differentiation of human B lymphocytes and the secretion of IgG. Blood. 2003;101:3065\u201373.","journal-title":"Blood"},{"key":"8599_CR36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jaut.2011.05.014","volume":"37","author":"JF S\u00e9it\u00e9","year":"2011","unstructured":"S\u00e9it\u00e9 JF, Guerrier T, Cornec D, Jamin C, Youinou P, Hillion S. TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase. J Autoimmun. 2011;37:190\u20137.","journal-title":"J Autoimmun"},{"key":"8599_CR37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","volume":"25","author":"SR Christensen","year":"2006","unstructured":"Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006;25:417\u201328.","journal-title":"Immunity"},{"key":"8599_CR38","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/art.24760","volume":"60","author":"M Visentini","year":"2009","unstructured":"Visentini M, Conti V, Cagliuso M, Tinti F, Siciliano G, Trombetta AC, et al. Regression of systemic lupus erythematosus after development of an acquired toll-like receptor signaling defect and antibody deficiency. Arthritis Rheum. 2009;60:2767\u201371.","journal-title":"Arthritis Rheum"},{"key":"8599_CR39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jaci.2014.03.017","volume":"134","author":"M Visentini","year":"2014","unstructured":"Visentini M, Marrapodi R, Conti V, Mitrevski M, Camponeschi A, Lazzeri C, et al. Dysregulated extracellular signal-regulated kinase signaling associated with impaired B-cell receptor endocytosis in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134:401\u201310.","journal-title":"J Allergy Clin Immunol"},{"key":"8599_CR40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/ni924","volume":"4","author":"L Rui","year":"2003","unstructured":"Rui L, Vinuesa CG, Blasioli J, Goodnow CC. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat Immunol. 2003;4:594\u2013600.","journal-title":"Nat Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-014-8599-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-014-8599-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-014-8599-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:06:20Z","timestamp":1559441180000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-014-8599-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,19]]},"references-count":40,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["8599"],"URL":"https:\/\/doi.org\/10.1007\/s12026-014-8599-8","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,19]]}}}